BiondVax Pharmaceuticals Ltd.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$531,000 over the previous period. Total operating expenses were $11,061,000.
Profit Margin
| 2013 | 0 | -8.03M | |
|---|---|---|---|
| 2014 | 0 | -7.76M | |
| 2015 | 0 | -10.19M | |
| 2016 | 0 | -9.18M | |
| 2017 | 0 | -34.55M | |
| 2018 | 0 | -23.29M | |
| 2019 | 0 | -124.11M | |
| 2020 | 0 | 6.81M | |
| 2021 | 2.74M | -50.81M | -1848.98% |
| 2022 | 0 | -531K |
BVXV Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 2.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 2.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 5.76M | 10.34M | 16.00M | 68.64M | 19.09M | 18.77M | 7.79M | 7.90M | 5.49M | 5.45M |
Selling and marketing | 0 | 0 | -10.94M | 0 | -3.72M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 11.06M | 34.82M | -2.28M | 78.35M | 20.46M | 23.65M | 11.9M | 11.30M | 8.14M | 7.64M |
Operating income | -11.06M | -34.82M | 1.03M | -78.35M | -20.46M | -23.65M | -11.9M | -11.30M | -8.14M | -7.64M |
Other income (expenses), net | 5.26M | -5.14M | -2.42M | -30.84M | 2.83M | -10.89M | 2.66M | 1.10M | 378K | -395K |
Income before tax | -5.79M | -39.97M | -1.38M | -109.19M | -23.29M | -34.55M | -9.18M | -10.19M | -7.76M | -8.03M |
Income tax expense | -5.26M | 10.83M | -8.20M | 14.91M | 2.88M | 10.89M | -55K | -11K | 0 | 0 |
Net income | -531K | -50.81M | 6.81M | -124.11M | -23.29M | -34.55M | -9.18M | -10.19M | -7.76M | -8.03M |
Earnings per share | ||||||||||
Basic EPS | 0 | -36 | 6.15 | -151.98 | -35.64 | -68.75 | -27.19 | -38.66 | -23.76 | -24.59 |
Diluted EPS | 0 | -36 | 6.15 | -151.98 | -35.64 | -68.75 | -27.19 | -38.66 | -23.76 | -24.59 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |